Purchase Order HT001416P0662
- Not listed
- Life Technologies Corporation, operating as Thermo Fisher Scientific, was awarded a firm fixed-price purchase order valued at $10,924.97 by the Defense Health Agency's Bureau of Medicine and Surgery on April 23, 2025. The contract, which builds upon previous purchase order N3239824P0311, carries an ultimate completion date of April 23, 2026 and will be performed at the Silver Spring, Maryland location. No set-aside designation was used for this award, reflecting the contractor's competitive...
- This $545,029.48 firm fixed-price Blanket Purchase Agreement (BPA) Call contract was awarded by the Defense Health Agency (DHA) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is for the delivery of reagents and has a performance period through June 14, 2024. Life Technologies, a division of Thermo Fisher Scientific, has experience as a prime contractor supporting diverse federal agencies including the National Institutes of...
- This is a $110,565.00 firm-fixed-price Blanket Purchase Agreement (BPA) call awarded by the Defense Health Agency (DHA) to Life Technologies Corporation, a division of Thermo Fisher Scientific. The contract is for the supply of reagents and laboratory consumables to support the DHA's biomedical research, healthcare, and medical readiness missions. As the prime contractor, Life Technologies will provide a range of specialized biotechnology products and services, including genetic analyzers,...
- Life Technologies Corporation, a manufacturer of scientific instruments and reagents, was awarded a $114,683.32 firm-fixed-price delivery order against an existing indefinite-delivery vehicle with the Defense Health Agency. The delivery order is for POP-4 polymer to support genetic sequencing platforms at the agency's facility in Carlsbad, California, with performance through February 2028. As a division of Thermo Fisher Scientific, Life Technologies leverages its expertise in proprietary life...
- Life Technologies Corporation, operating as Thermo Fisher Scientific, was awarded a Blanket Purchase Agreement (BPA) call contract by the Defense Health Agency for reagents with a ceiling value of $1.025M and an ultimate completion date of September 12, 2025. This firm fixed-price contract, awarded on May 22, 2025, will be performed in Carlsbad, California. The contract carries no set-aside designation, reflecting the contractor's competitive standing in federal procurement. As a leading...
- This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, is for DNA analysis equipment and services. The $585,136.93 Firm Fixed Price contract was awarded by the Defense Health Agency and has a completion date of January 3, 2025. The contract is a Blanket Purchase Agreement (BPA) call order, indicating it is part of a larger indefinite delivery vehicle. Life Technologies has been awarded multiple federal contracts and grant sub-awards,...
- The Defense Health Agency awarded a firm-fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for the delivery of a genetic analyzer. The $494,929.40 contract has a completion date of September 30, 2021 and does not utilize any set-aside designations. Life Technologies Corporation, a division of Thermo Fisher Scientific, has provided similar products and services to various federal agencies, including the NIH, DoD,...
- This federal contract award is for the supply of Life Technology reagents and consumables to the Defense Health Agency. The firm fixed price delivery order, valued at $547,715.16, was awarded on July 23, 2018 to Life Technologies Corporation, a for-profit manufacturer of scientific instruments, reagents, and consumables. The contract does not have a set-aside designation. Life Technologies has experience delivering a range of biomedical research, medical readiness, and forensic analysis products...
- This is a $901,600.23 firm-fixed-price purchase order contract awarded by the U.S. Department of Health and Human Services (HHS) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to provide laboratory supplies. The contract is not set aside for any specific program. Life Technologies is a leading manufacturer of scientific instruments, reagents, and consumables that supports biomedical research, applied markets, and forensic analysis across various federal agencies,...
- This federal contract award is for $4,014.72 to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, to provide scientific instruments, reagents, and consumables to support biomedical research, applied markets, and forensic analysis for the U.S. Department of Defense's Bureau of Medicine and Surgery. The contract is a firm fixed price purchase order with a completion date of September 30, 2016. Life Technologies has served as a prime contractor across multiple federal...
This contract award to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc., is for the provision of laboratory supplies to the Defense Health Agency (DHA), a component of the U.S. Department of Defense. The $120,000.00 firm-fixed-price purchase order has an ultimate completion date of March 10, 2020 and was awarded on March 10, 2016. The contract does not have any set-aside designations. Life Technologies is an established provider of biomedical research and genetic analysis tools and technologies to government agencies and academic institutions. Through this contract, the company has supplied the DHA with a range of specialized products, services, and consumables to support its research, healthcare, and public health missions. Life Technologies also holds two significant indefinite delivery contracts with the Department of Veterans Affairs to provide genome reagents and sequencing supplies in support of the VA's precision medicine initiatives and enhanced healthcare services for veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $30.0k | 2/22/17 | |
| Not listed | Not listed | $30.0k | 3/10/16 |